|
|
|
|
|
| Introducing Laminar Airflow Technology In Aseptic Processing | Article | By Trista Hager, AES Cleanroom Technology | The global market for injectable drugs will reach $69.13 billion by 2028. Examine the vital role of laminar airflow technology in meeting sterile integrity standards and minimizing contamination risks. |
|
|
| Work With An In-Country Depot For Efficiency And Compliance | Article | By Soudeh F. Tehrani, Lisa Lemelin, and Anh-Thu Le, Ropack Pharma Solutions | If you’re launching an international clinical trial, consider the noteworthy benefits of partnering with an in-country depot, including increased efficiency, reduced costs, and reliable access to raw materials. |
|
|
|
|
|
By Katie Anderson, Chief Editor, Pharmaceutical Online | What an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D. | |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
| Expanding The Viscosity Limits Of Peristaltic Dosing | White Paper | By Harry Price, 3P innovation | Discover how innovations in closed-loop control and mechanical design extend peristaltic dosing limits to 2000 cP, maintaining accuracy while preserving the advantages of sterile, disposable paths. |
|
|
|
| Continuous Manufacturing For API Breakthroughs | White Paper | Curia | Observe how a compound library, designed for chemical diversity and lead-like properties, uses advanced filtering to improve hit discovery and early-stage small molecule drug discovery. |
|
|
| Integrated Annex 1 Compliance | Article | By Declan O’Shea, Dec Group | Read about the critical changes in the Annex 1 guidance from a process equipment provider's perspective, several areas where process and product change could take place, and more. |
|
|
| Enabling The Future Of Intensified Biomanufacturing | White Paper | Sartorius | Process intensification demands smarter orchestration, real-time analytics, and scalable automation. Discover how digital infrastructure enables synchronized, compliant, and predictive biomanufacturing. |
|
|
|
|
|
|
| The Non-Opioid Pain Therapeutics Summit provides a dedicated platform to harness the current momentum in the pain space. Attendees will be learning from companies with approvals such as Tonix and Vertex, exploring late-stage strategies from innovators like Latigo and Algiax, and uncovering discovery breakthroughs from Nocion and Axonis. Join discovery, preclinical, translational and clinical industry-based experts driving the future of non-opioid pain therapies. |
|
|
|
|
|
|
|
|
|
| Connect With Pharmaceutical Online: |
|
|
|